Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures

Detalhes bibliográficos
Autor(a) principal: Pibarot, Philippe
Data de Publicação: 2018
Outros Autores: Simonato, Matheus [UNIFESP], Barbanti, Marco, Linke, Axel, Kornowski, Ran, Rudolph, Tanja, Spence, Mark, Moat, Neil, Aldea, Gabriel, Mennuni, Marco, Iadanza, Alessandro, Amrane, Hafid, Gaia, Diego [UNIFESP], Kim, Won-Keun, Napodano, Massimo, Baumbach, Hardy, Finkelstein, Ariel, Kobayashi, Junjiro, Brecker, Stephen, Don, Creighton, Cerillo, Alfredo, Unbehaun, Axel, Attias, David, Nejjari, Mohammed, Jones, Noah, Fiorina, Claudia, Tchetche, Didier, Philippart, Raphael, Spargias, Konstantinos, Hernandez, Jose-Maria, Latib, Azeem, Dvir, Danny
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
dARK ID: ark:/48912/001300000sb9k
Texto Completo: http://dx.doi.org/10.1016/j.jcin.2017.08.039
https://repositorio.unifesp.br/handle/11600/54255
Resumo: OBJECTIVES The aim of this study was to determine whether the association of small label size of the surgical valve with increased mortality after transcatheter valve-in-valve (ViV) implantation is, at least in part, related to pre-existing prosthesis-patient mismatch (PPM) (i.e., a bioprosthesis that is too small in relation to body size). BACKGROUND Transcatheter ViV implantation is an alternative for the treatment of patients with degenerated bioprostheses. Small label size of the surgical valve has been associated with increased mortality after ViV implantation. METHODS Data from 1,168 patients included in the VIVID (Valve-in-Valve International Data) registry were analyzed. Pre-existing PPM of the surgical valve was determined using a reference value of effective orifice area for each given model and size of implanted prosthetic valve indexed for body surface area. Severe PPM was defined according to the criteria proposed by the Valve Academic Research Consortium 2: indexed effective orifice area <0.65 cm(2)/m(2) if body mass index is < 30 kg/m(2) and < 0.6 cm(2)/m(2) if BMI is >= 30 kg/m(2). The primary study endpoint was 1-year mortality. RESULTS Among the 1,168 patients included in the registry, 89 (7.6%) had pre-existing severe PPM. Patients with severe PPM had higher 30-day (10.3%, p = 0.01) and 1-year (unadjusted: 28.6%, p < 0.001 adjusted: 19.3%, p = 0.03) mortality rates compared with patients with no severe PPM (4.3%, 11.9%, and 10.9%, respectively). After adjusting for surgical valve label size, Society of Thoracic Surgeons score, renal failure, diabetes, and stentless surgical valves, presence of pre-existing severe PPM was associated with increased risk for 1-year mortality (odds ratio: 1.88 95% confidence interval: 1.07 to 3.28 p = 0.03). Patients with severe PPM also more frequently harbored high post-procedural gradients (mean gradient >= 20 mm Hg). CONCLUSIONS Pre-existing PPM of the failed surgical valve is strongly and independently associated with increased risk for mortality following ViV implantation. (C) 2018 by the American College of Cardiology Foundation.
id UFSP_059c9c1ae12898426807c0b1190b9daa
oai_identifier_str oai:repositorio.unifesp.br/:11600/54255
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Proceduresprosthesis-patient-mismatchtranscatheter aortic valve replacementvalve-in-valveOBJECTIVES The aim of this study was to determine whether the association of small label size of the surgical valve with increased mortality after transcatheter valve-in-valve (ViV) implantation is, at least in part, related to pre-existing prosthesis-patient mismatch (PPM) (i.e., a bioprosthesis that is too small in relation to body size). BACKGROUND Transcatheter ViV implantation is an alternative for the treatment of patients with degenerated bioprostheses. Small label size of the surgical valve has been associated with increased mortality after ViV implantation. METHODS Data from 1,168 patients included in the VIVID (Valve-in-Valve International Data) registry were analyzed. Pre-existing PPM of the surgical valve was determined using a reference value of effective orifice area for each given model and size of implanted prosthetic valve indexed for body surface area. Severe PPM was defined according to the criteria proposed by the Valve Academic Research Consortium 2: indexed effective orifice area <0.65 cm(2)/m(2) if body mass index is < 30 kg/m(2) and < 0.6 cm(2)/m(2) if BMI is >= 30 kg/m(2). The primary study endpoint was 1-year mortality. RESULTS Among the 1,168 patients included in the registry, 89 (7.6%) had pre-existing severe PPM. Patients with severe PPM had higher 30-day (10.3%, p = 0.01) and 1-year (unadjusted: 28.6%, p < 0.001 adjusted: 19.3%, p = 0.03) mortality rates compared with patients with no severe PPM (4.3%, 11.9%, and 10.9%, respectively). After adjusting for surgical valve label size, Society of Thoracic Surgeons score, renal failure, diabetes, and stentless surgical valves, presence of pre-existing severe PPM was associated with increased risk for 1-year mortality (odds ratio: 1.88 95% confidence interval: 1.07 to 3.28 p = 0.03). Patients with severe PPM also more frequently harbored high post-procedural gradients (mean gradient >= 20 mm Hg). CONCLUSIONS Pre-existing PPM of the failed surgical valve is strongly and independently associated with increased risk for mortality following ViV implantation. (C) 2018 by the American College of Cardiology Foundation.Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin St Foy, Quebec City, PQ G1V 4G5, CanadaEscola Paulista Med UNIFESP, Sao Paulo, BrazilFerraroto Hosp, Catania, ItalyUniv Leipzig, Leipzig, GermanyRabin Med Ctr, Petah Tiqwa, IsraelUniklin Koln Herzzentrum, Cologne, GermanyBelfast Hlth & Social Care Trust, Belfast, Antrim, North IrelandRoyal Brompton Harefield NHS Fdn Trust, London, EnglandUniv Washington, Seattle, WA 98195 USAHumanitas Hosp, Milan, ItalyUniv Senese, Azienda Osped, Siena, ItalyMed Centrum Leeuwarden, Leeuwarden, NetherlandsKerckhoff Klin, Bad Nauheim, GermanyUniv Padua, Padua, ItalyRobert Bosch Krankenhaus, Stuttgart, GermanyTel Aviv Sourasky Med Ctr, Tel Aviv, IsraelNatl Cerebral & Cardiovasc Ctr, Osaka, JapanSt Georges Univ London, London, EnglandFdn Toscana Gabriele Monasterio, Pisa, ItalyDeutsch Herzzentrum Berlin, Berlin, GermanyCtr Cardiol Nord, St Denis, FranceMount Carmel Columbus, Columbus, OH USASpedali Civili Brescia, Brescia, ItalyClin Pasteur, Toulouse, FranceHygeia Hosp, Athens, GreeceHospl Univ Virgen Victoria, Malaga, SpainOspede San Raffaele, Milan, ItalyEscola Paulista Med UNIFESP, Sao Paulo, BrazilWeb of ScienceCanadian Institutes of Health ResearchEdwards LifesciencesMedtronicAbbottCanadian Institutes of Health Research: FDN-143225Elsevier Science Inc2020-07-08T13:09:51Z2020-07-08T13:09:51Z2018info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion133-141http://dx.doi.org/10.1016/j.jcin.2017.08.039Jacc-Cardiovascular Interventions. New York, v. 11, n. 2, p. 133-141, 2018.10.1016/j.jcin.2017.08.0391936-8798https://repositorio.unifesp.br/handle/11600/54255WOS:000422763200008ark:/48912/001300000sb9kengJacc-Cardiovascular InterventionsNew Yorkinfo:eu-repo/semantics/openAccessPibarot, PhilippeSimonato, Matheus [UNIFESP]Barbanti, MarcoLinke, AxelKornowski, RanRudolph, TanjaSpence, MarkMoat, NeilAldea, GabrielMennuni, MarcoIadanza, AlessandroAmrane, HafidGaia, Diego [UNIFESP]Kim, Won-KeunNapodano, MassimoBaumbach, HardyFinkelstein, ArielKobayashi, JunjiroBrecker, StephenDon, CreightonCerillo, AlfredoUnbehaun, AxelAttias, DavidNejjari, MohammedJones, NoahFiorina, ClaudiaTchetche, DidierPhilippart, RaphaelSpargias, KonstantinosHernandez, Jose-MariaLatib, AzeemDvir, Dannyreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2021-10-05T21:43:43Zoai:repositorio.unifesp.br/:11600/54255Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:34:58.363510Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
title Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
spellingShingle Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
Pibarot, Philippe
prosthesis-patient-mismatch
transcatheter aortic valve replacement
valve-in-valve
title_short Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
title_full Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
title_fullStr Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
title_full_unstemmed Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
title_sort Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures
author Pibarot, Philippe
author_facet Pibarot, Philippe
Simonato, Matheus [UNIFESP]
Barbanti, Marco
Linke, Axel
Kornowski, Ran
Rudolph, Tanja
Spence, Mark
Moat, Neil
Aldea, Gabriel
Mennuni, Marco
Iadanza, Alessandro
Amrane, Hafid
Gaia, Diego [UNIFESP]
Kim, Won-Keun
Napodano, Massimo
Baumbach, Hardy
Finkelstein, Ariel
Kobayashi, Junjiro
Brecker, Stephen
Don, Creighton
Cerillo, Alfredo
Unbehaun, Axel
Attias, David
Nejjari, Mohammed
Jones, Noah
Fiorina, Claudia
Tchetche, Didier
Philippart, Raphael
Spargias, Konstantinos
Hernandez, Jose-Maria
Latib, Azeem
Dvir, Danny
author_role author
author2 Simonato, Matheus [UNIFESP]
Barbanti, Marco
Linke, Axel
Kornowski, Ran
Rudolph, Tanja
Spence, Mark
Moat, Neil
Aldea, Gabriel
Mennuni, Marco
Iadanza, Alessandro
Amrane, Hafid
Gaia, Diego [UNIFESP]
Kim, Won-Keun
Napodano, Massimo
Baumbach, Hardy
Finkelstein, Ariel
Kobayashi, Junjiro
Brecker, Stephen
Don, Creighton
Cerillo, Alfredo
Unbehaun, Axel
Attias, David
Nejjari, Mohammed
Jones, Noah
Fiorina, Claudia
Tchetche, Didier
Philippart, Raphael
Spargias, Konstantinos
Hernandez, Jose-Maria
Latib, Azeem
Dvir, Danny
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pibarot, Philippe
Simonato, Matheus [UNIFESP]
Barbanti, Marco
Linke, Axel
Kornowski, Ran
Rudolph, Tanja
Spence, Mark
Moat, Neil
Aldea, Gabriel
Mennuni, Marco
Iadanza, Alessandro
Amrane, Hafid
Gaia, Diego [UNIFESP]
Kim, Won-Keun
Napodano, Massimo
Baumbach, Hardy
Finkelstein, Ariel
Kobayashi, Junjiro
Brecker, Stephen
Don, Creighton
Cerillo, Alfredo
Unbehaun, Axel
Attias, David
Nejjari, Mohammed
Jones, Noah
Fiorina, Claudia
Tchetche, Didier
Philippart, Raphael
Spargias, Konstantinos
Hernandez, Jose-Maria
Latib, Azeem
Dvir, Danny
dc.subject.por.fl_str_mv prosthesis-patient-mismatch
transcatheter aortic valve replacement
valve-in-valve
topic prosthesis-patient-mismatch
transcatheter aortic valve replacement
valve-in-valve
description OBJECTIVES The aim of this study was to determine whether the association of small label size of the surgical valve with increased mortality after transcatheter valve-in-valve (ViV) implantation is, at least in part, related to pre-existing prosthesis-patient mismatch (PPM) (i.e., a bioprosthesis that is too small in relation to body size). BACKGROUND Transcatheter ViV implantation is an alternative for the treatment of patients with degenerated bioprostheses. Small label size of the surgical valve has been associated with increased mortality after ViV implantation. METHODS Data from 1,168 patients included in the VIVID (Valve-in-Valve International Data) registry were analyzed. Pre-existing PPM of the surgical valve was determined using a reference value of effective orifice area for each given model and size of implanted prosthetic valve indexed for body surface area. Severe PPM was defined according to the criteria proposed by the Valve Academic Research Consortium 2: indexed effective orifice area <0.65 cm(2)/m(2) if body mass index is < 30 kg/m(2) and < 0.6 cm(2)/m(2) if BMI is >= 30 kg/m(2). The primary study endpoint was 1-year mortality. RESULTS Among the 1,168 patients included in the registry, 89 (7.6%) had pre-existing severe PPM. Patients with severe PPM had higher 30-day (10.3%, p = 0.01) and 1-year (unadjusted: 28.6%, p < 0.001 adjusted: 19.3%, p = 0.03) mortality rates compared with patients with no severe PPM (4.3%, 11.9%, and 10.9%, respectively). After adjusting for surgical valve label size, Society of Thoracic Surgeons score, renal failure, diabetes, and stentless surgical valves, presence of pre-existing severe PPM was associated with increased risk for 1-year mortality (odds ratio: 1.88 95% confidence interval: 1.07 to 3.28 p = 0.03). Patients with severe PPM also more frequently harbored high post-procedural gradients (mean gradient >= 20 mm Hg). CONCLUSIONS Pre-existing PPM of the failed surgical valve is strongly and independently associated with increased risk for mortality following ViV implantation. (C) 2018 by the American College of Cardiology Foundation.
publishDate 2018
dc.date.none.fl_str_mv 2018
2020-07-08T13:09:51Z
2020-07-08T13:09:51Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.jcin.2017.08.039
Jacc-Cardiovascular Interventions. New York, v. 11, n. 2, p. 133-141, 2018.
10.1016/j.jcin.2017.08.039
1936-8798
https://repositorio.unifesp.br/handle/11600/54255
WOS:000422763200008
dc.identifier.dark.fl_str_mv ark:/48912/001300000sb9k
url http://dx.doi.org/10.1016/j.jcin.2017.08.039
https://repositorio.unifesp.br/handle/11600/54255
identifier_str_mv Jacc-Cardiovascular Interventions. New York, v. 11, n. 2, p. 133-141, 2018.
10.1016/j.jcin.2017.08.039
1936-8798
WOS:000422763200008
ark:/48912/001300000sb9k
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Jacc-Cardiovascular Interventions
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 133-141
dc.coverage.none.fl_str_mv New York
dc.publisher.none.fl_str_mv Elsevier Science Inc
publisher.none.fl_str_mv Elsevier Science Inc
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1818602511220604928